After initial infection, human cytomegalovirus remains in a persistent state with the host.
Immunity against the virus controls replication, although intermitent viral shedding can still …

Human cytomegalovirus (HCMV) is a herpesvirus that infects~ 60% of adults in developed
countries and more than 90% in developing countries. Usually, it is controlled by a vigorous …

Cytomegalovirus is the most frequent cause of intrauterine infection and the commonest
infectious agent to affect allograft recipients, yet the virus is acknowledged rarely as an …

Opinion statement In treating cytomegalovirus (CMV) infection, it is crucial to decide whether
one is treating pre-emptively or if one is treating established disease. Disease may be …

Background Human cytomegalovirus (HCMV) is a threat to immunologically weak patients.
HCMV cannot yet be eliminated with a vaccine, despite recent advances. Sources of data …

Human cytomegalovirus (HCMV), a betaherpesvirus, represents the major infectious cause
of birth defects, as well as an important pathogen for immunocompromised individuals. The …

Cytomegalovirus (CMV) is an opportunistic pathogen associated with significant morbidity
and mortality in immunocompromised hosts. Antiviral agents specifically targeting CMV were …

Following primary infection, human cytomegalovirus (HCMV) establishes lifelong latency
and periodically reactivates without causing symptoms in healthy individuals. In the absence …

Human cytomegalovirus (HCMV) is a recognized cause of disease in the fetus, the allograft
recipient and AIDS patients. More recently, it has been recognized as a pathogen for those …

Human cytomegalovirus (CMV), one of the eight herpesviruses that commonly infect
humans, is best known for its propensity to cause disease in immunocompromised patients …